论文部分内容阅读
生物企业作为新兴的智力密集型生物企业,与信息技术生物企业等其它高新技术生物企业相比较,具有研发和产业化周期长、对资源依赖性强和对人才实验操作技能要求高等典型特征。在过去的30年,生命科学和生物技术的飞速发展,为医学界打开了广阔的发展空间。中国作为一个大国,13多亿人口在健康领域面临严峻的挑战,危害人体健康的各种疾病的预防和治疗水平有待提高,再加上经济和科技全球化以及中国加入世贸组织,为生物产业更好、更快发展,提供了机遇和挑战。
Compared with other hi-tech biological enterprises such as information technology bio-enterprises, bio-enterprises, as the emerging intellectual-intensive bio-enterprises, are characterized by long cycle of research and development and industrialization, high dependence on resources and high requirements on the experimental operation of qualified personnel. In the past 30 years, the rapid development of life sciences and biotechnology has opened up a vast space for medical development. As a big country, China’s population of over 1.3 billion faces serious challenges in the field of health. The level of prevention and treatment of various diseases endangering human health needs to be improved. Coupled with the globalization of economy and science and technology and China’s accession to the WTO, Good, faster development offers opportunities and challenges.